Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis

Summary

The purpose of this study is to determine whether PR022 Topical Gels are safe and effective treatments for mild-to-moderate atopic dermatitis (AD).

Timeline

Start

2017-12-04

Primary completion

2018-04

Completion

2018-07

Outcome

Missed primary endpoint

release “top-line results of its Phase 2 trial of PR022 in Atopic Dermatitis which did not meet” essapharma.com ↗

Drugs

Indications